first_img Sign up for our daily newsletter Get more great content like this delivered right to you! Country TOKYO—Tying up a loose end of a long-running stem cell research fiasco, yet another RIKEN investigating committee released yet another report in Tokyo today. It concludes that the so-called stimulus-triggered acquisition of pluripotency (STAP) stem cells, as well as the chimeric mice and teratomas supposedly derived from those cells, “all originated in cultures contaminated with (embryonic stem) cells, a fact that refutes all of the main conclusions of the two papers” that reported the the supposed breakthrough method of reprogramming adult cells. Those two papers, an article and a letter, appeared online in Nature on 29 January.The committee determined that three supposed STAP stem cell lines were actually likely to be three previously existing embryonic stem (ES) cell lines. “It is unlikely that there was accidental contamination by three different ES cells, and it is suspected that the contamination may have occurred artificially,” the committee concluded in a report released today. However the panel could not find conclusive evidence of deliberate contamination, nor of who might be responsible. “We cannot, therefore, conclude that there was research misconduct in this instance,” the committee reported.However, the committee did find “research misconduct involving fabrication” in the production of two images in the article that had no supporting experimental data. The images are Fig. 5c: Growth curves of STAP stem cells and Fig. 2c: DNA methylation. The committee laid responsibility for the fabrications on Haruko Obokata, the lead author of both papers. Click to view the privacy policy. Required fields are indicated by an asterisk (*) Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwecenter_img Email The committee’s announcement came a week after a separate RIKEN group announced it could not reproduce the STAP cell method even with Obokata’s help. The same day, Obokata resigned from the RIKEN Center for Developmental Biology (CDB) in Kobe, home to most of the research team.A previous investigating committee had looked at the papers and reported on 1 April that Obokata was guilty of two counts of misconduct for fabricating and falsifying images. That committee only investigated six specific allegations of image manipulation. Nature retracted the papers in July. This second investigating committee was formed in September to take a closer look at the papers in response to additional allegations of problematic images. It relied on sequencing and other genetic analyses of materials taken from the Wakayama and Obokata labs; a review of notebooks, documents, and e-mails; and interviews with involved researchers.While blaming Obokata for the misconduct, the committee cited two senior researchers as bearing “heavy responsibility” for lax oversight. One is Teruhiko Wakayama, who headed the RIKEN laboratory in which Obokata worked; the other is Yoshiki Sasai, who had a major role in writing the papers. Wakayama, now at the University of Yamanashi in Kofu, previously said that he would accept some sort of disciplinary action for his role in the scandal. Sasai committed suicide in August as investigations were under way. Only one senior author is still at RIKEN, Hitoshi Niwa. A separate disciplinary committee will decide if he or any higher-ups should be disciplined. RIKEN, which manages a network of national laboratories, has already restructured CDB, cutting its staff by nearly half.One of the papers’ co-authors has been beyond the reach of RIKEN investigators: Charles Vacanti, a tissue engineer at Brigham and Women’s Hospital in Boston, an affiliate of Harvard Medical School. Obokata initiated her work on STAP cells while a postdoc in Vacanti’s lab. Mutsuhiro Arinobu, a RIKEN executive director, said that although they have been in contact with Harvard, input from Vacanti “is not included in this investigation.”last_img